BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression

BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype

(2011) Manuela Santarosa et al.   CANCER AND METASTASIS REVIEWS

Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer

(2011) Alok Kumar Singh et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis

(2010) Laura De Vargas Roditi et al.   JOURNAL OF THEORETICAL BIOLOGY

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

(2010) Andrew Tutt et al.   LANCET

Expression of BRCA1 protein in breast cancer and its prognostic significance

(2008) Emad A. Rakha et al.   HUMAN PATHOLOGY

Clinical significance of promoter hypermethylation of RASSF1A, RARβ2, BRCA1 and HOXA5 in breast cancers of Indian patients

(2008) Sarangadhara Appala Raju Bagadi et al.   LIFE SCIENCES